{"disease":{"id":"treatment-of-adult-patients-with-hormone-receptor-hr-positive-human-epidermal-growth-factor-receptor-2-her2-negative-advanced-or-metastatic-breast-cancer-in-combination-with-fulvestrant-in-patients-with-disease-progression-following-endocrine-therapy.md","name":"treatment of adult patients with hormone receptor hr positive human epidermal growth factor receptor 2 her2 negative advanced or metastatic breast cancer in combination with fulvestrant in patients with disease progression following endocrine therapy.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}